Cargando…
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
Human Ebola virus causes severe hemorrhagic fever disease with high mortality and there is no vaccine or treatment. Antibodies in survivors occur early, are sustained, and can delay infection when transferred into nonhuman primates. Monoclonal antibodies (mAbs) from survivors exhibit potent neutrali...
Autores principales: | Shedlock, Devon J., Bailey, Michael A., Popernack, Paul M., Cunningham, James M., Burton, Dennis R., Sullivan, Nancy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351102/ https://www.ncbi.nlm.nih.gov/pubmed/20304456 http://dx.doi.org/10.1016/j.virol.2010.02.029 |
Ejemplares similares
-
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
por: Oswald, Wendelien B, et al.
Publicado: (2007) -
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs
por: Sullivan, Nancy J, et al.
Publicado: (2006) -
Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016) -
Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017
por: Fischer, Kerstin, et al.
Publicado: (2020) -
Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
por: Patel, Seema R., et al.
Publicado: (2022)